Arrowstreet Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $701M | Sell |
|
|||||
2025
Q1 | $681M | Buy |
|
|||||
2024
Q4 | $499M | Buy |
|
|||||
2024
Q3 | $428M | Buy |
|
|||||
2024
Q2 | $371M | Sell |
|
|||||
2024
Q1 | $336M | Sell |
|
|||||
2023
Q4 | $350M | Sell |
|
|||||
2023
Q3 | $403M | Sell |
|
|||||
2023
Q2 | $481M | Buy |
|
|||||
2023
Q1 | $427M | Buy |
|
|||||
2022
Q4 | $392M | Buy |
|
|||||
2022
Q3 | $304M | Buy |
|
|||||
2022
Q2 | $281M | Buy |
|
|||||
2022
Q1 | $241M | Buy |
|
|||||
2021
Q4 | $139M | Buy |
|
|||||
2021
Q3 | $38.3M | Buy |
|
|||||
2021
Q2 | $1.28M | Buy |
|
|||||
2021
Q1 | – | Sell |
|
|||||
2020
Q4 | $8.73M | Buy |
|
|||||
2020
Q3 | $332K | Sell |
|
|||||
2020
Q2 | $2.92M | Sell |
|
|||||
2020
Q1 | $65.7M | Buy |
|
|||||
2019
Q2 | – | Sell |
|
|||||
2019
Q1 | $242K | Sell |
|
|||||
2018
Q4 | $375K | Buy |
|
|||||
2018
Q2 | – | Sell |
|
|||||
2018
Q1 | $24M | Sell |
|
|||||
2017
Q4 | $177M | Buy |
|
|||||
2017
Q3 | $44.2M | Sell |
|
|||||
2017
Q2 | $55.8M | Sell |
|
|||||
2017
Q1 | $119M | Buy |
|
|||||
2016
Q4 | – | Sell |
|
|||||
2016
Q3 | $61.1M | Buy |
|
|||||
2016
Q2 | $14.6M | Buy |
|
|||||
2016
Q1 | $4.66M | Buy |
|
|||||
2015
Q4 | – | Sell |
|
|||||
2015
Q3 | $671K | Sell |
|
|||||
2015
Q2 | $4.91M | Sell |
|
|||||
2015
Q1 | $29.3M | Sell |
|
|||||
2014
Q4 | $48.1M | Buy |
|
|||||
2014
Q3 | $20.2M | Sell |
|
|||||
2014
Q2 | $25.5M | Sell |
|
|||||
2014
Q1 | $114M | Sell |
|
|||||
2013
Q4 | $114M | Buy |
|
|||||
2013
Q3 | $88.9M | Buy |
|
|||||
2013
Q2 | $54.7M | Buy |
|